Both in Biotechnology
X4 Pharmaceuticals vs Fennec Pharmaceuticals
Over the past year XFOR returned −18.1% and FENC returned +26.0%; their daily moves had a correlation of 0.18.
XFOR −18.1% FENC +26.0%Growth of $1, one year, split-adjusted
| Metric | XFOR | FENC |
|---|---|---|
| Price | $3.35 | $10.24 |
| Market cap | $332.1M | $359.1M |
| Today | −0.30% | −6.48% |
| 1 month | +18.4% | −0.9% |
| 6 months | −20.0% | +56.6% |
| Year to date | −16.3% | +33.0% |
| 1 year | −10.4% | +20.9% |
| Revenue growth (YoY) | +346.3% | +85.2% |
| Gross margin | 81.6% | 96.0% |
| Net margin | −183.5% | 11.0% |
| P/E (TTM) | — | — |
| Price / sales | 21.0× | 6.1× |
| Net cash | $131.2M | $41.2M |
| Dividend yield | — | — |
| Volatility (60d) | 66.2% | 57.5% |
| Short % of float | 9.3% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).